Mar 15–18, 2026 | Fairmont Le Château Frontenac, Québec, QC, Canada
Scientific Organizers:
Jennifer Guerriero, Thomas Marron, Ira Mellman, and Solange Peters

-
Scientific Organizers: Jennifer Guerriero, Thomas Marron, Ira Mellman, and Solange Peters
Jennifer Guerriero, PhD
Brigham and Women's Hospital
Thomas Marron, MD, PhD
Icahn School of Medicine at Mount Sinai
Ira Mellman, PhD
Parker Institute for Cancer Immunotherapy
Solange Peters, MD, PhD
CHUV
***Meeting program subject to change.
Available Formats: = In Person = On DemandSunday, March 15, 2026
Fundraising
Booking Function
Merchandise Options
Registration Options
Monday, March 16, 2026
Cancer Immunotherapy - Where do we Stand Now?
Postmortem of Failed Immunotherapy Approaches
Talk Title to be Announced
The Future of Cancer Immunotherapy
The Gut Microbiome as a Therapeutic Target in Immuno-oncology
From the Clinic to the Lab: Investigating Mechanisms of Response and Resistance to Immune Checkpoint Therapy
Vaccines
Tuesday, March 17, 2026
Challenges and Opportunities to Improve Responses to Radiation and Immunotherapy Combinations
How to Optimally Combine Chemotherapies and Targeted Therapies with Immunotherapy
Neoadjuvant Combination Immunotherapy Approaches: Improving Outcomes and Propelling the Science
Immune Checkpoint Blockade in Cancer Immunotherapy: Mechanistic Insights Provide New Therapeutic Opportunities
Talk Title to be Announced
Crosstalk between Eosinophils and Adaptive Immune Cells: A New Avenue for Immune Checkpoint Blockade
Harnessing Macrophages for Anti-Cancer Therapy
Wednesday, March 18, 2026
B Cells
Novel Insights into the Organization of TLS
Novel T Cell Checkpoints
Cellular Therapies
Factors of TME Resistance
Clonal Evolution and Immune Evasion
Thursday, March 19, 2026
Subscribe for Updates